Beckman Coulter/Princeton BioMeditech agreement
In a move that underscores its growing commitment to the market for rapid diagnostic medical test products, Beckman Coulter has entered into a supply relationship with Princeton BioMeditech (PBM). Under the agreement, PBM will supply a wide range of rapid diagnostic tools used at the point of medical care to Beckman Coulter's Primary Care Diagnostics business unit (PCD).
Princeton BioMeditech is a leading innovator and manufacturer of simple and rapid diagnostic products used at the point of care. The company offers more than 70 tests covering fertility management, infectious diseases, cardiac markers, drugs of abuse, cancer markers, environmental and veterinary diagnostics that enable consumers and professionals to improve speed and quality of diagnosis for better patient care.
Evident names 5th Annual Image of the Year Award winners
View the six winning entries in Evident's 5th Annual Image of the Year Award — a...
Fellowships and scholarships support women in science
The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing...
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...
